Literature DB >> 11032833

Activation of hepatocyte growth factor (HGF) by endogenous HGF activator is required for metanephric kidney morphogenesis in vitro.

J van Adelsberg1, S Sehgal, A Kukes, C Brady, J Barasch, J Yang, Y Huan.   

Abstract

The interaction of hepatocyte growth factor (HGF) with c-Met has been implicated in morphogenesis of the kidney, lung, mammary gland, liver, placenta, and limb bud. HGF is secreted as an inactive zymogen and must be cleaved by a serine protease to initiate Met signaling. We show here that a serine protease specific for HGF, HGF activator (HGFA), is expressed and activated by the ureteric bud of the developing kidney in vivo and in vitro. Inhibition of HGFA activity with serine protease inhibitors reduced ureteric bud branching and inhibited glomerulogenesis and nephrogenesis. Activated HGF rescued developing kidneys from the effects of inhibitors. HGFA was localized around the tips of the ureteric bud in developing kidneys, while HGF was expressed diffusely throughout the mesenchyme. These data show that expression of HGF is not sufficient for development, but that its activation is also required. The localization of HGFA to the ureteric bud and the mesenchyme immediately adjacent to it suggests that HGFA creates a gradient of HGF activity in the developing kidney. The creation and shape of gradients of activated HGF by the localized secretion of HGF activators could play an important role in pattern formation by HGF responsive tissues.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032833     DOI: 10.1074/jbc.M006634200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Concise review: can the intrinsic power of branching morphogenesis be used for engineering epithelial tissues and organs?

Authors:  Sanjay K Nigam
Journal:  Stem Cells Transl Med       Date:  2013-11-04       Impact factor: 6.940

2.  Hepatocyte growth factor system in the mouse uterus: variation across the estrous cycle and regulation by 17-beta-estradiol and progesterone.

Authors:  Xuan Zhang
Journal:  Biol Reprod       Date:  2010-02-10       Impact factor: 4.285

3.  The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells.

Authors:  Benedetta Peruzzi; Gagani Athauda; Donald P Bottaro
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

Review 4.  VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma.

Authors:  W Marston Linehan; Jeffrey S Rubin; Donald P Bottaro
Journal:  Int J Biochem Cell Biol       Date:  2008-10-02       Impact factor: 5.085

Review 5.  Targeting the Met signaling pathway in renal cancer.

Authors:  Alessio Giubellino; W Marston Linehan; Donald P Bottaro
Journal:  Expert Rev Anticancer Ther       Date:  2009-06       Impact factor: 4.512

6.  Synergistic signaling of tumor cell invasiveness by hepatocyte growth factor and hypoxia.

Authors:  Young H Lee; Bethanie L Morrison; Donald P Bottaro
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

Review 7.  Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling.

Authors:  Ognoon Mungunsukh; Elizabeth A McCart; Regina M Day
Journal:  Biomedicines       Date:  2014-11-05

8.  A distinct cardiopharyngeal mesoderm genetic hierarchy establishes antero-posterior patterning of esophagus striated muscle.

Authors:  Glenda Comai; Eglantine Heude; Sebastian Mella; Sylvain Paisant; Francesca Pala; Mirialys Gallardo; Francina Langa; Gabrielle Kardon; Swetha Gopalakrishnan; Shahragim Tajbakhsh
Journal:  Elife       Date:  2019-09-19       Impact factor: 8.140

Review 9.  Role of cancer cell-stroma interaction in invasive growth of cancer cells.

Authors:  Hiroaki Kataoka; Hiroyuki Tanaka; Koki Nagaike; Shuichiro Uchiyama; Hiroshi Itoh
Journal:  Hum Cell       Date:  2003-03       Impact factor: 4.374

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.